Class IITerminatedD-1567-2014
Drug recall · September 3, 2014
Glycopyrrolate 0.2 mg/ml recall
Why: Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only. Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd., Noblesville, IN 46060, NDC#: 45183-0965-70.
- Lots / codes
Lot #: E131210.212 Exp: 07/14/2014
- Quantity
- 200 Syringes
- Company
- Pharmakon Pharmaceuticals, Noblesville, IN
- Distribution
- United States: TX, IL, MD, IN
- Initiated
- April 21, 2014 · Voluntary: Firm initiated
- Classified
- August 26, 2014
- Reported
- September 3, 2014
- Ended
- December 3, 2014
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class ITerminatedSep 3, 2014Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC VialPharmakon Pharmaceuticals · D-1565-2014Class ITerminatedSep 3, 2014Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bagPharmakon Pharmaceuticals · D-1566-2014Class ITerminatedSep 3, 2014Atropine Sulfate 0.4 mg/ml InjectionPharmakon Pharmaceuticals · D-1568-2014
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.